Evidence map›Paper›PMID 39866919›Full record

ArticleJCEM case reports2025

Tumor-Induced Osteomalacia Localized by Systemic Venous Sampling and

Tomomi Nakao, Ken Takeshima, Shuhei Morita, Ichiro Yamauchi, Sho Koyasu, Taka-Aki Matsuoka

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tomomi NakaoFirst Department of Internal Medicine, Wakayama Medical University, Wakayama City, Wakayama 641-8509, Japan.
Ken TakeshimaFirst Department of Internal Medicine, Wakayama Medical University, Wakayama City, Wakayama 641-8509, Japan.ORCID https://orcid.org/0000-0002-2364-5018
Shuhei MoritaFirst Department of Internal Medicine, Wakayama Medical University, Wakayama City, Wakayama 641-8509, Japan.ORCID https://orcid.org/0000-0002-4415-3805
Ichiro YamauchiDepartment of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.ORCID https://orcid.org/0000-0002-4236-502X
Sho KoyasuDepartment of Radiology, Kyoto University Hospital, Kyoto 606-8507, Japan.
Taka-Aki MatsuokaFirst Department of Internal Medicine, Wakayama Medical University, Wakayama City, Wakayama 641-8509, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-induced osteomalacia is characterized by hypophosphatemia and fragility fractures caused by fibroblast growth factor 23 (FGF23)-producing tumors. We report a case of tumor-induced osteomalacia in which the tumor location could be determined by gallium 68 (

Indexed as

111In-pentetreotide scintigraphy68Ga-DOTATOC-PET/CTfibroblast growth factor 23systemic venous samplingtumor-induced osteomalacia

Identifiers

PMID39866919
PMCPMC11758137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.